Recent Quotes (30 days)

You have no recent quotes
chg | %

Healthcare News

Showing stories 1 - 10 of about 70   
Johnson & Johnson wins California lawsuit claiming asbestos in talc caused cancer
(Reuters) - A California jury on Thursday ruled in favor of Johnson & Johnson in a lawsuit by a woman who said she developed the cancer mesothelioma after being exposed to asbestos in the company's talc-based products including J&J's Baby Powder.
Johnson & Johnson not liable for woman's asbestos sickness, jury rules  New York Daily News
Johnson & Johnson CEO reveals the leadership lessons he learned at West Point
Alex Gorsky, CEO of Johnson and Johnson speaks with Jim Cramer on Mad Money at the U.S. Military Academy at West Point on Nov. 9th, 2017.
Johnson & Johnson hit with $247 million verdict in hip implant trial
NEW YORK (Reuters) - A federal jury in Dallas on Thursday ordered Johnson & Johnson and its DePuy Orthopaedics unit to pay $247 million to six patients who said they were injured by defective Pinnacle hip implants.
Dallas jury orders Johnson & Johnson to pay $247 million to hip implant ...  Dallas News
Johnson & Johnson fined $247M in hip implant case
J&J has now lost three Pinnacle legal fights on the bounce since winning the first test case in 2014. Share Facebook Twitter LinkedIn Email Print.
Johnson & Johnson Will Pay Millions for Metal on Metal Hip Implants  Legal Examiner
Johnson & Johnson granted new trial over $417m ovarian cancer award
Bottles of Johnson & Johnson baby powder line a drugstore shelf in New York. Photograph: Lucas Jackson/Reuters. Pharmaceuticals industry.
California judge tosses $417 million talc cancer verdict against Johnson ...  Reuters
Judge tosses $417m award Johnson & Johnson was ordered to pay woman in ...  Toronto Star
Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to ...
SAN FRANCISCO, Nov. 13, 2017 /PRNewswire/ -- Johnson & Johnson Innovation LLC, in collaboration with Johnson & Johnson Consumer Inc., today announced the launch of the Digital Beauty QuickFire Challenge.
The Right Time To Buy Johnson & Johnson
Impressive pharma pipeline has JNJ in a position of recognizing significant future top line growth. Based on a DCF, DDM, and comps model, JNJ is certainly not on the clearance rack, but has an enticing valuation for the benefits you get from the stock.
Johnson & Johnson (NYSE:JNJ) Shares Sold by Johnston Asset Management LLC  The Ledger Gazette
Critical Comparison: Pfizer Inc. (PFE) vs. Johnson & Johnson (JNJ)  StockNewsGazette
Judge Reverses Record $417 Million Verdict Against Johnson & Johnson Over ...
Johnson and Johnson won its second consecutive legal victory in one week after a judge reversed a record $417 million jury verdict against the health giant over alleged links between ovarian cancer and its talc based products.
Judge overturns $417M verdict over Johnson & Johnson baby powder  Ars Technica
Judge overturns record verdict in Johnson & Johnson talcum powder trial - WISC-TV3
Johnson & Johnson CEO: Washington needs to work with us for 'smart tax policy'
"Mad Money" host Jim Cramer spoke to Johnson & Johnson Chairman and CEO Alex Gorsky about the role of government and employing veterans.
Johnson & Johnson launches surgery patient support platform
Johnson & Johnson has announced a suite of digital tools designed for patients preparing to undergo or recovering from knee, hip, and weight loss surgery.